James Caci Sells 20,215 Shares of AvePoint, Inc. (NASDAQ:AVPT) Stock

AvePoint, Inc. (NASDAQ:AVPT) CFO James Caci sold 20,215 shares of AvePoint stock in a transaction on Wednesday, November 20th. The stock was sold at an average price of $17.12, for a total transaction of $346,080.80. Following the sale, the chief financial officer now directly owns 591,890 shares of the company’s stock, valued at $10,133,156.80. This represents a 3.30 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link.

AvePoint Price Performance

AVPT stock opened at $18.57 on Friday. AvePoint, Inc. has a one year low of $7.08 and a one year high of $18.75. The stock has a market cap of $3.47 billion, a PE ratio of -371.33 and a beta of 0.88. The firm has a 50 day simple moving average of $13.04 and a two-hundred day simple moving average of $11.14.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of AVPT. SG Americas Securities LLC lifted its stake in shares of AvePoint by 44.2% in the 1st quarter. SG Americas Securities LLC now owns 16,727 shares of the company’s stock valued at $132,000 after purchasing an additional 5,125 shares during the period. ProShare Advisors LLC lifted its position in AvePoint by 12.5% during the first quarter. ProShare Advisors LLC now owns 33,857 shares of the company’s stock valued at $268,000 after purchasing an additional 3,749 shares in the last quarter. Vanguard Group Inc. lifted its position in shares of AvePoint by 3.7% in the first quarter. Vanguard Group Inc. now owns 15,050,278 shares of the company’s stock valued at $119,198,000 after acquiring an additional 532,371 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its position in shares of AvePoint by 14.3% in the first quarter. Price T Rowe Associates Inc. MD now owns 42,464 shares of the company’s stock valued at $337,000 after acquiring an additional 5,316 shares in the last quarter. Finally, Bayesian Capital Management LP bought a new stake in shares of AvePoint in the first quarter worth about $130,000. Institutional investors own 44.49% of the company’s stock.

Wall Street Analyst Weigh In

AVPT has been the topic of several analyst reports. Northland Securities boosted their price target on shares of AvePoint from $18.00 to $19.00 and gave the stock an “outperform” rating in a research report on Friday, August 9th. Cantor Fitzgerald upped their price target on shares of AvePoint from $11.00 to $13.00 and gave the company an “overweight” rating in a research note on Friday, August 9th. Finally, The Goldman Sachs Group upped their price target on shares of AvePoint from $7.50 to $15.00 and gave the company a “neutral” rating in a research note on Tuesday, November 12th. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $13.20.

About AvePoint

AvePoint, Inc provides cloud-native data management software platform in North America, Europe, Middle East, Africa, and Asia Pacific. It also offers software-as-a-service solutions and productivity applications. The company offers modularity and cloud services architecture to address critical challenges and the management of data to organizations that leverage third-party cloud vendors, including Microsoft, Salesforce, Google, AWS, Box, DropBox, and others; license and support; and maintenance services.